Market Access
Market Access Strategy That Protects Economic Credibility.
Market Access Strategy That Protects Economic Credibility.
Market Access connects the product story to economic reality.
This is where clinical evidence must translate into system-level value, payer relevance, and reimbursement defensibility. If value is retrofitted or inconsistently framed, resistance emerges quickly.
We work with access and HEOR leaders to define a coherent economic position early, ensuring pricing strategy, value messaging, and HTA materials reinforce the same defensible product truth under payer scrutiny.
Our Services Include:
- Global and regional value proposition development
- Cost-effectiveness and burden-of-illness evidence summaries
- HTA strategy planning and workshop facilitation
- AMCP dossiers, HTA briefing materials, and local objection handlers
- Payer slide decks and evidence communication tools
- Efficient localisation, evidence mapping, and comparator landscape scanning using validated workflows
These services are delivered within a unified economic narrative architecture, ensuring every value dossier, payer deck, and workshop reinforces the same defensible access position.
Case Studies
Biotech | EU – Market Access Payer
Readiness for TED Biologic
Challenge:
A global biologic programme approaching payer engagement lacked a unified economic narrative across HEOR evidence, value messaging, and regional HTA expectations.
Solution:
We defined a payer-relevant value architecture first, aligning HEOR outputs, workshop materials, and cross-regional positioning around a coherent and defensible access thesis.
Impact: Stronger internal alignment, clearer payer-facing positioning, and more confident HTA discussions under scrutiny across regions.
